Class III antiarrhythmics vs control
All‐cause mortality · Human trial participants undergoing ablation for atrial fibrillation
It is very uncertain whether class III antiarrhythmics changes all‐cause mortality compared with control (very low certainty).
1 finding from 1 review
- Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation 2023 · Cochrane Headline outcomes onlyPeto OR 0.13 [0, 6.57]1 study · 212 participantsVery low